Search For "hcq"
Remdesivir helps to decrease hospital stay, doesn't show benefit in mortal
Updated : 5 years, 9 months ago IST
New Delhi [India], June 12 (ANI): Remdesivir helps to decrease hospital stay but the benefits don't reflect as far as death or mortality benefit is concerned, All India Institute of Medical Sciences (AIIMS), New Delhi Director Dr Randeep Guleria said on Friday.
Read More
India sees a record spike of over 10,950 COVID-19 cases as total count rea
Updated : 5 years, 9 months ago IST
New Delhi [India], June 12 (ANI): India's new coronavirus cases rose by over 10,950 on Friday, the steepest increase so far, with the total number of reported cases crossing 2.97 lakh.
Read More
Fighting Covid: Govt mulling to discontinue Azithromycin on critical patie
Updated : 5 years, 9 months ago IST
New Delhi [India], June 12 (ANI): The Ministry of Health and Family Welfare is likely to withdraw the use of Azithromycin, which was being administered to severely ill COVID-19 patients in the intensive care units (ICUs), from the combination of Azithromycin and Hydroxychloroquine (HCQ).<
Read More
Restricted, emergency use of Remdesivir, Tocilizumab likely for treating C
Updated : 5 years, 9 months ago IST
New Delhi [India], June 11 (ANI): Remdesivir, an antiviral drug and Tocilizumab, an immunomodulator, are being considered by the Union Health Ministry for 'restricted, emergency use' and on 'compassionate grounds' to treat severely ill COVID-19 patients.
Read More
Production of Hydroxychloroquine more than requirement: Mansukh Mandaviya
Updated : 5 years, 9 months ago IST
New Delhi [India], June 11 (ANI): Union Minister of State for Chemicals and Fertilizers, Mansukh Mandaviya said that the production of Hydroxychloroquine is more than the requirement in India, hence the government has lifted export restrictions on it.
Read More
Authors retract Lancet study on HCQ drug over unavailability of full data
Updated : 5 years, 9 months ago IST
Washington D.C. [USA], June 5 (ANI): Three authors involved in a Lancet article that drew scrutiny over the trial of the antimalarial drug-- hydroxychloroquine-- for curing patients infected with COVID-19 said they retracted items related to it over unavailability of full data set behind the
Read More
WHO decision to stop HCQ trial was a knee jerk reaction, says CSIR DG
Updated : 5 years, 9 months ago IST
New Delhi [India], June 4 (ANI): CSIR Director-General Shekhar Mande said on Thursday that the World Health Organisation's (WHO) decision to halt hydroxychloroquine (HCQ) drug trial was taken in haste and the global body should have actually analysed the data before making the decision.
Read More
Four or more dosage of HCQ showed significant decline of covid19 among hea
Updated : 5 years, 9 months ago IST
New Delhi [India], June 1 (ANI): Citing noteworthy benefits of Hydroxychloroquine (HCQ) prophylaxis against coronavirus, the Indian Council of Medical Research (ICMR) has revealed that the consumption of four or more doses of the antimalarial drug- (HCQ), has shown a significant decline of C
Read More
Halting hydroxychloroquine trials based on faulty Lancet study is 'knee je
Updated : 5 years, 9 months ago IST
New Delhi [India], May 30 (ANI): Council of Scientific and Industrial Research (CSIR) Director-General Shekhar Mande, Institute of Genomics and Integrative Biology (IGIB) Delhi Director Anurag Agarwal and Chennai Mathematical Institute (CMI) Chennai Director Rajeev Karandikar have written to
Read More
ICMR writes to WHO disagreeing with HCQ assessment, officials say internat
Updated : 5 years, 9 months ago IST
New Delhi [India], May 29 (ANI): After the Union Health Ministry expressed reservations about the World Health Organisation's (WHO) advisory to suspend hydroxychloroquine (HCQ) usage in treating COVID-19 patients, now, India's nodal government agency ICMR (Indian Council of Medical Research)
Read More
Trust ICMR's judgement on hydroxychloroquine in covid treatment, says CSIR
Updated : 5 years, 9 months ago IST
New Delhi [India], May 27 (ANI): Director General of the Council of Scientific and Industrial Research (CSIR), Shekher Mande, on Wednesday said the Indian Council of Medical Research's (ICMR) conclusion of hydroxychloroquine (HCQ) having no major side-effects in the treatment of Covid-inf
Read More
Lancet study is not randomised clinical trial, only analysis of hospital r
Updated : 5 years, 9 months ago IST
New Delhi [India], May 27 (ANI): Dismissing the reports of health risks from Hydroxychloroquine (HCQ) as per simmering reports cited by the World Health Organisation (WHO), Shekher Mande, Director General of the Council of Scientific and Industrial Research (CSIR), India, said on Wednesday t
Read More